Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment
Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now.
Argenx Se (ARGX)
Market is closed
News
- 1 - 10
- Next >>
13 Best Biotech Stocks To Invest In Now
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
argenx SE (ARGX): A Bull Case Theory
We came across a bullish thesis on argenx SE (ARGX) by Simvestor08 on r/valueinvesting on Reddit.. In this article, we will summarize the bulls’ thesis on ARGX.
Barclays Boosts Argenx (ARGX) PT to EUR 680 After Strong Q1 2025 Performance
On June 4, Barclays raised its price target for Argenx (NASDAQ:ARGX) from EUR 650 to EUR 680, while keeping an Overweight rating on the company's shares.
10 Stocks Analysts Are Upgrading Today
The easing of the US-China trade war is the catalyst driving equity markets higher after weeks of heightened volatility.
12 Best Growth Stocks to Buy and Hold for the Long Term
The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a returning positive sentiment.
argenx SE (NASDAQ:ARGX) Q1 2025 Earnings Call Transcript
Operator: Good morning. My name is Rob, and I will be your conference operator today. I would like to welcome everyone to the call.
10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
argenx SE (ARGX): A Bull Case Theory
We came across a bullish thesis on argenx SE (ARGX) on Substack by FluentInQuality. In this article, we will summarize the bulls’ thesis on ARGX.
13 Most Profitable Growth Stocks to Buy Now
The growth factor in investing refers to companies that grow their revenue and earnings at rates significantly above the market.
- 1 - 10
- Next >>
Billionaire Hedge Funds
